EROAD Fiscal 2025 H1 Results Meets Expectations; Maintenance of Guidance 'Disappointing', Jarden Research Says

MT Newswires Live

2024/11/27

EROAD's (ASX:ERD, NZE:ERD) fiscal 2025 guidance is "disappointing", Jarden Research said in a Nov.25 note.

EROAD reported revenue of NZ$95.9 million for the six months ended Sept. 30, up 8% from its revenue of NZ$ 88.9 million in the same period a year earlier.

For the fiscal year ending June 30, 2025, EROAD expects revenue between NZ$190 million to NZ$195 million, EBIT between NZ$5 million to NZ$10 million, and R&D spending of NZ$35 million, up from NZ$32 million last year.

The company said it was "on track" to meet the guidance.

Jarden believes that the guidance will not let the company achieve the fiscal 2026 revenue CAGR target of over 11% to 13%, which is in line with market growth expectations.

"Maintenance of FY25 guidance is disappointing given the required execution to meet FY26 targets", Jarden added.

The investment firm maintained EROAD's neutral rating but raised its target price to NZ$1.05 from NZ$0.96.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2486890917"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2486890917\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2486890917?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-27 14:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486890917","market":"hk","top_or_hot":-1,"title":"EROAD Fiscal 2025 H1 Results Meets Expectations; Maintenance of Guidance 'Disappointing', Jarden Research Says","media":"MT Newswires Live","content":"<html><body><p> EROAD's (ASX:ERD, NZE:ERD) fiscal 2025 guidance is \"disappointing\", Jarden Research said in a Nov.25 note.</p><p>EROAD reported revenue of NZ$95.9 million for the six months ended Sept. 30, up 8% from its revenue of NZ$ 88.9 million in the same period a year earlier.</p><p>For the fiscal year ending June 30, 2025, EROAD expects revenue between NZ$190 million to NZ$195 million, EBIT between NZ$5 million to NZ$10 million, and R&amp;D spending of NZ$35 million, up from NZ$32 million last year.</p><p>The company said it was \"on track\" to meet the guidance.</p><p>Jarden believes that the guidance will not let the company achieve the fiscal 2026 revenue CAGR target of over 11% to 13%, which is in line with market growth expectations.</p><p>\"Maintenance of FY25 guidance is disappointing given the required execution to meet FY26 targets\", Jarden added.</p><p>The investment firm maintained EROAD's neutral rating but raised its target price to NZ$1.05 from NZ$0.96.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EROAD Fiscal 2025 H1 Results Meets Expectations; Maintenance of Guidance 'Disappointing', Jarden Research Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEROAD Fiscal 2025 H1 Results Meets Expectations; Maintenance of Guidance 'Disappointing', Jarden Research Says\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-11-27 14:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> EROAD's (ASX:ERD, NZE:ERD) fiscal 2025 guidance is \"disappointing\", Jarden Research said in a Nov.25 note.</p><p>EROAD reported revenue of NZ$95.9 million for the six months ended Sept. 30, up 8% from its revenue of NZ$ 88.9 million in the same period a year earlier.</p><p>For the fiscal year ending June 30, 2025, EROAD expects revenue between NZ$190 million to NZ$195 million, EBIT between NZ$5 million to NZ$10 million, and R&amp;D spending of NZ$35 million, up from NZ$32 million last year.</p><p>The company said it was \"on track\" to meet the guidance.</p><p>Jarden believes that the guidance will not let the company achieve the fiscal 2026 revenue CAGR target of over 11% to 13%, which is in line with market growth expectations.</p><p>\"Maintenance of FY25 guidance is disappointing given the required execution to meet FY26 targets\", Jarden added.</p><p>The investment firm maintained EROAD's neutral rating but raised its target price to NZ$1.05 from NZ$0.96.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7084","symbol_name":"電子設備和儀器","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2486890917","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486890917","pubTimestamp":1732689633,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EROAD's  fiscal 2025 guidance is \"disappointing\", Jarden Research said in a Nov.25 note.EROAD reported revenue of NZ$95.9 million for the six months ended Sept. 30, up 8% from its revenue of NZ$ 88.9 million in the same period a year earlier.For the fiscal year ending June 30, 2025, EROAD expects revenue between NZ$190 million to NZ$195 million, EBIT between NZ$5 million to NZ$10 million, and R&D spending of NZ$35 million, up from NZ$32 million last year.The company said it was \"on track\" to meet the guidance.Jarden believes that the guidance will not let the company achieve the fiscal 2026 revenue CAGR target of over 11% to 13%, which is in line with market growth expectations.\"Maintenance of FY25 guidance is disappointing given the required execution to meet FY26 targets\", Jarden added.The investment firm maintained EROAD's neutral rating but raised its target price to NZ$1.05 from NZ$0.96.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7084":"电子设备和仪器","ERD.AU":"EROAD LTD"},"translate_title":"eRoad 2025财年上半年业绩符合预期；贾登研究公司表示，维持指导意见“令人失望”","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ERD.AU":0.9},"content_text":"EROAD's (ASX:ERD, NZE:ERD) fiscal 2025 guidance is \"disappointing\", Jarden Research said in a Nov.25 note.EROAD reported revenue of NZ$95.9 million for the six months ended Sept. 30, up 8% from its revenue of NZ$ 88.9 million in the same period a year earlier.For the fiscal year ending June 30, 2025, EROAD expects revenue between NZ$190 million to NZ$195 million, EBIT between NZ$5 million to NZ$10 million, and R&D spending of NZ$35 million, up from NZ$32 million last year.The company said it was \"on track\" to meet the guidance.Jarden believes that the guidance will not let the company achieve the fiscal 2026 revenue CAGR target of over 11% to 13%, which is in line with market growth expectations.\"Maintenance of FY25 guidance is disappointing given the required execution to meet FY26 targets\", Jarden added.The investment firm maintained EROAD's neutral rating but raised its target price to NZ$1.05 from NZ$0.96.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}